Inhibition of Rho Kinase (ROCK) With Fasudil as Disease-modifying Treatment for ALS

NCT03792490 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: Fasudil
DRUG: Placebo

Sponsor

University Medical Center Goettingen